Home»Exposition»FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

0
Shares
Pinterest Google+

RESEARCH TRIANGLE PARK, N.C., Aug. 14, 2019 /PRNewswire/ — Today, the Food and Drug Administration (FDA) announced its approval of pretomanid, a new drug developed to treat Extensively Drug-Resistant Tuberculosis (XDR-TB) and treatment intolerant/non-responsive Multidrug-Resistant (MDR)…

Previous post

Colin Jones Wins $3,375,000+ Verdict in LA County Motorcycle Accident Case

Next post

PetSafe® Introduces New Ricochet Electronic Dog Toys